home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Turning Point Therapeutics Announces New Preclinical Data for Three Drug Candidates
Turning Point Therapeutics Announces New Preclinical Data for Three Drug Candidates
Post navigation
Previous Post
Previous
Silverback Therapeutics to Present SBT6290 Preclinical Data at the AACR 2021 Annual Conference
Next Post
Next
Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting